Join Professors Tina Vilsbøll and Naveed Sattar as they discuss two papers from the world of cardiometabolic disease research.

The first compares the effects of canagliflozin and metformin on insulin resistance and visceral adipose tissue in people with newly-diagnosed T2D.

The second assesses the efficacy of semaglutide among an east Asian population of adults with overweight or obesity. Each month, two of our steering committee members discuss the latest research in cardiometabolic diseases. Everything discussed is available in a more detailed slide format in the publications section at cardiometabolicforum.com.